Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer

Clinical trial NCT05588219 · UNKNOWN

Trial details

NCT number: NCT05588219
Sponsor: Yong Zhang,MD
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Cervical Neoplasms

Start date: 2022-12-01
Primary completion: 2024-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.